7,144 Shares in UnitedHealth Group Incorporated $UNH Bought by Arlington Partners LLC

Key Points

• Arlington Partners LLC acquired 7,144 shares of UnitedHealth Group, valued at approximately $2,229,000, during the second quarter.
• Institutional investors now own 87.86% of UnitedHealth Group's stock, with significant recent purchases from firms like Vanguard Group Inc. and Wellington Management Group LLP.
• The company's quarterly earnings report revealed a $4.08 EPS, missing the consensus estimate, with expected earnings per share of 29.54 for the current fiscal year.

Arlington Partners LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 7,144 shares of the healthcare conglomerate's stock, valued at approximately $2,229,000.

A number of other hedge funds have also modified their holdings of the company. Bayforest Capital Ltd grew its holdings in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after acquiring an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd grew its holdings in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after acquiring an additional 50 shares during the period. Copia Wealth Management acquired a new stake in UnitedHealth Group during the fourth quarter worth about $42,000. IAG Wealth Partners LLC acquired a new stake in UnitedHealth Group in the first quarter valued at approximately $42,000. Finally, O Brien Wealth Partners LLC grew its holdings in UnitedHealth Group by 74.0% in the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock valued at $46,000 after purchasing an additional 37 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have commented on the company. KeyCorp dropped their price objective on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Bank of America raised their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a report on Monday, August 18th. Oppenheimer decreased their target price on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Truist Financial raised their target price on UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a research report on Tuesday, September 9th. Finally, Barclays raised their target price on UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a research report on Thursday, September 4th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $358.95.

UnitedHealth Group Trading Up 1.4%

NYSE:UNH traded up $4.80 on Monday, reaching $341.49. The company's stock had a trading volume of 8,883,715 shares, compared to its average volume of 13,684,542. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market cap of $309.27 billion, a price-to-earnings ratio of 14.80, a price-to-earnings-growth ratio of 2.20 and a beta of 0.44. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The stock has a 50 day moving average price of $296.49 and a 200 day moving average price of $362.50.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group's quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's payout ratio is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.